BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14722329)

  • 21. Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers.
    Furness MS; Zhang X; Coop A; Jacobson AE; Rothman RB; Dersch CM; Xu H; Porreca F; Rice KC
    J Med Chem; 2000 Aug; 43(16):3193-6. PubMed ID: 10956228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.
    Bishop MJ; Garrido DM; Boswell GE; Collins MA; Harris PA; McNutt RW; O'Neill SJ; Wei K; Chang KJ
    J Med Chem; 2003 Feb; 46(4):623-33. PubMed ID: 12570383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different regulation of human delta-opioid receptors by SNC-80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and endogenous enkephalins.
    Lecoq I; Marie N; Jauzac P; Allouche S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):666-77. PubMed ID: 15102931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of delta-opioid receptor function in neurogenesis and neuroprotection.
    Narita M; Kuzumaki N; Miyatake M; Sato F; Wachi H; Seyama Y; Suzuki T
    J Neurochem; 2006 Jun; 97(5):1494-505. PubMed ID: 16696856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
    Chang KJ; Rigdon GC; Howard JL; McNutt RW
    J Pharmacol Exp Ther; 1993 Nov; 267(2):852-7. PubMed ID: 8246159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic social stress on delta-opioid receptor function in the rat.
    Pohorecky LA; Skiandos A; Zhang X; Rice KC; Benjamin D
    J Pharmacol Exp Ther; 1999 Jul; 290(1):196-206. PubMed ID: 10381776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
    Hosohata Y; Vanderah TW; Burkey TH; Ossipov MH; Kovelowski CJ; Sora I; Uhl GR; Zhang X; Rice KC; Roeske WR; Hruby VJ; Yamamura HI; Lai J; Porreca F
    Eur J Pharmacol; 2000 Feb; 388(3):241-8. PubMed ID: 10675732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
    Brandt MR; Negus SS; Mello NK; Furness MS; Zhang X; Rice KC
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1157-64. PubMed ID: 10454490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine-independent psychostimulant activity of a delta-agonist.
    Ito S; Mori T; Sawaguchi T
    Behav Pharmacol; 2008 Mar; 19(2):113-9. PubMed ID: 18332675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor.
    Quock RM; Hosohata Y; Knapp RJ; Burkey TH; Hosohata K; Zhang X; Rice KC; Nagase H; Hruby VJ; Porreca F; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1997 May; 326(1):101-4. PubMed ID: 9178661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
    Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics.
    Banks ML; Folk JE; Rice KC; Negus SS
    Pharmacol Biochem Behav; 2010 Dec; 97(2):205-12. PubMed ID: 20678514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and pharmacological evaluation of SNC80 analogues with a bridged piperazine ring.
    Holl R; Jung B; Schepmann D; Humpf HU; Grünert R; Bednarski PJ; Englberger W; Wünsch B
    ChemMedChem; 2009 Dec; 4(12):2111-22. PubMed ID: 19827086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward analgesic tolerance.
    Pradhan AA; Walwyn W; Nozaki C; Filliol D; Erbs E; Matifas A; Evans C; Kieffer BL
    J Neurosci; 2010 Dec; 30(49):16459-68. PubMed ID: 21147985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw.
    Romero A; Planas E; Poveda R; Sánchez S; Pol O; Puig MM
    Eur J Pharmacol; 2005 Mar; 511(2-3):207-17. PubMed ID: 15792790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.
    Saland LC; Abeyta A; Frausto S; Raymond-Stintz M; Hastings CM; Carta M; Valenzuela CF; Savage DD
    Alcohol Clin Exp Res; 2004 Jan; 28(1):98-104. PubMed ID: 14745307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide.
    Kim IJ; Ullrich T; Janetka JW; Furness MS; Jacobson AE; Rothman RB; Dersch CM; Flippen-Anderson JL; George C; Rice KC
    Bioorg Med Chem; 2003 Nov; 11(22):4761-8. PubMed ID: 14556791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents.
    Saitoh A; Kimura Y; Suzuki T; Kawai K; Nagase H; Kamei J
    J Pharmacol Sci; 2004 Jul; 95(3):374-80. PubMed ID: 15272214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.
    Thompson CM; Wojno H; Greiner E; May EL; Rice KC; Selley DE
    J Pharmacol Exp Ther; 2004 Feb; 308(2):547-54. PubMed ID: 14600248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mu and delta opioid-stimulated [35S]GTP gamma S binding in brain and spinal cord of polyarthritic rats.
    Cichewicz DL; Cox ML; Welch SP; Selley DE; Sim-Selley LJ
    Eur J Pharmacol; 2004 Nov; 504(1-2):33-8. PubMed ID: 15507218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.